Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction

Prenatal Diagnosis

Volumn 16, Issue 8, 1996, Pages 723-727

  Groutz, Asnat ^a   Amit, Ami ^a   Yaron, Yuval ^a   Yovel, Israel ^a   Wolman, Igal ^a   Legum, Cyril ^a   Lessing, Joseph B ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b Serlin Maternity Hospital   (Israel)

Author keywords

hCG; MSAFP; Multifetal pregnancy reduction; Twins; UE3

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GESTATIONAL AGE; HUMAN; MATERNAL SERUM; OMPHALOCELE; PRENATAL SCREENING; PRIORITY JOURNAL; SCREENING TEST; SECOND TRIMESTER PREGNANCY; THERAPEUTIC ABORTION; TWIN PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; ESTRIOL; FEMALE; HUMANS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY REDUCTION, MULTIFETAL; PREGNANCY TRIMESTER, SECOND; PREGNANCY, MULTIPLE; REFERENCE VALUES; REPRODUCTIVE TECHNIQUES;

EID: 0029840252     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199608)16:8<723::AID-PD942>3.0.CO;2-W     Document Type: Article

References (21)

1. Beekhuis, J.R., VanLith, J.M.M., De Wolf, B.T.H.M., Mantingh, A. (1992). Increased maternal serum AFP and hCG in compromised pregnancies other than for NTDs or Down syndrome, Prenat. Diagn., 12, 643-647.
2. Bock, J.L. (1992). Current issues in maternal serum alpha-fetoprotein screening, Am. J. Clin. Pathol., 97, 541-554.
3. Cuckle, H., Wald, N., Stevenson, J.D., May, H.M., Ferguson-Smith, M.A., Milford Ward, A., Barbour, H.M., Laurence, K.M., Norgaardt-Pedersen, B. (1990). Maternal serum alpha-fetoprotein screening for open NTDs in twin pregnancies, Prenat. Diagn., 10, 71-77.
4. Evans, M.I., Dommergues, M., Timor-Tritsch, I., Zador, I.E., Wapner, R.J., Lynch, L., Dumez, Y., Goldberg, J.D., Nicolaides, K.H., Johnson, M.P., Golbus, M.S., Boulot, P., Aknin, A.J., Monteagudo, A., Berkowitz, R.L. (1994). Transabdominal versus transcervical and transvaginal multifetal pregnancy reduction: international collaborative experience of more than one thousand cases, Am. J. Obstet. Gynecol., 170, 902-909.
5. Ghosh, A., Woo, J.S.K., Rawlinson, H.A., FergusonSmith, M.A. (1982). Prognostic significance of raised serum alpha-fetoprotein levels in twin pregnancies, Br. J. Obstet. Gynaecol., 89, 817-820.
6. Gitlin, D. (1975). Normal biology of alpha-fetoprotein. Part I. Biology of alpha-fetoprotein, Ann. N. Y. Acad Sci., 259, 7-16.
7. Grau, P., Robinson, L., Tabsh, K., Crandall, B.F. (1990). Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction, Obstet. Gynecol., 76, 1042-1045.
8. Gross, S.J., Phillips, O.P., Shulman, L.P., Lawrette Bright, N., Dungan, J.S., Simpson, J.L., Elias, S. (1994). Adverse perinatal outcome in patients screenpositive for NTDs and fetal Down syndrome, Prenat. Diagn., 14, 609-613.
9. Johnson, J.M., Harman, C.R., Evans, J.A., MacDonald, K., Manning, F.A. (1990). Maternal serum alpha-fetoprotein in twin pregnancy, Am. J. Obstet. Gynecol., 162, 1020-1025.
10. Katz, V.L., Chescheir, N.C., Cefalo, R.C. (1990). Unexplained elevations of maternal serum alpha fetoprotein, Obstet. Gynecol. Surv., 45, 719-726.
11. Lynch, L., Berkowitz, R.L. (1993). Maternal serum alpha-fetoprotein and coagulation profiles after multifetal pregnancy reduction, Am. J. Obstet. Gynecol., 169, 987-990.
12. MacLennan, A.H. (1989). Multiple gestation. In: Creasy, R.K., Resnik, R. (Eds). Maternal Fetal Medicine: Principles and Practice, 2nd edn, Philadelphia: W. B. Saunders, 580-591.
13. Mueller-Heubach, H. (1984). Complications of multiple gestation, Clin. Obstet. Gynecol., 27, 1003-1013.
14. Redford, D.H.A., Whitfield, C.R. (1985). Maternal serum alpha-fetoprotein in twin pregnancies uncomplicated by NTDs, Am. J. Obstet. Gynecol., 152, 550-553.
15. Rose, N.C., Mennuti, M.T. (1993). Maternal serum screening for NTDs and fetal chromosomal abnormalities, West J. Med., 159, 312-317.
16. Sundaram, S.G., Goldstein, P.J., Manimekalai, S., Wenk, R.E. (1992). Alpha-fetoprotein and screening markers of congenital disease, Clin. Lab. Med., 12, 481-492.
17. Tanaka, M., Natori, M., Kohno, H., Ishimoto, H., Koboyashi, T., Nozawa, S. (1993). Fetal growth in patients with elevated maternal serum hCG levels, Obstet. Gynecol., 81, 341-343.
18. Thom, H., Buckland, C.M., Campbell, A.G.M., Thompson, B., Farr, V. (1984). Maternal serum alpha-fetoprotein in monozygotic and dizygotic twin pregnancies. Prenat. Diagn., 4, 341-346.
19. Thomas, R.L., Blakemore, K.J. (1990). Evaluation of elevations in maternal serum alpha fetoprotein - a review, Obstet. Gynecol. Surv., 45, 269-283.
20. Walker, E.M., Patel, N.B. (1986). Maternal serum alpha-fetoprotein, birthweight and perinatal death in twin pregnancy, Br. J. Obstet. Gynaecol., 93, 1191-1193.
21. Yovel, I., Yaron, Y., Amit, A., Botchan, A., David, M.P., Peyser, M.R., Lessing, J.B. (1992). Embryo reduction in multifetal pregnancies using saline injection: comparing the transvaginal with transabdominal approach, Hum. Reprod., 7, 1173-1175.